Garnasa, Marga .
HRN: 26-92-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/03/2025
04/09/2025
IV
200mg
Q6H
PCAP B, AGE With Mod Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes